Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             78 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute coronary syndromes: recent achievements and future aspects Huber, K.
 1998
 12 S2 p. 67-89
23 p.
 artikel
2 Author index 1998
 12 S2 p. 121-122
2 p.
 artikel
3 Engineered staphylokinase variants with reduced immunogenicity Collen, D.
 1998
 12 S2 p. 59-65
7 p.
 artikel
4 P05 Acute myocardial infarction — time is survival. The munich AMI Project 1998
 12 S2 p. 92-
1 p.
 artikel
5 P44 Analysis of reperfusion of the culprit coronary artery after thrombolysis in acute myocardial infarction 1998
 12 S2 p. 105-
1 p.
 artikel
6 P64 A new rapid assay for determination of total clottable fibrinogen in plasma using 96-well microfiltration 1998
 12 S2 p. 112-
1 p.
 artikel
7 P48 Angiocopic control of embolectomy 1998
 12 S2 p. 106-
1 p.
 artikel
8 P09 Anticoagulation with LMW-heparin in patients with artificial heart valves 1998
 12 S2 p. 93-
1 p.
 artikel
9 P28 A randomized single blind trial of 2-hour regimens of alteplase and streptokinase in acute massive pulmonary embolism 1998
 12 S2 p. 99-
1 p.
 artikel
10 P59 Are there differences in outcome of patients with unstable angina pectoris Braunwald class III versus Braunwald classes I/II treated with coronary angioplasty 1998
 12 S2 p. 110-
1 p.
 artikel
11 P26 Avoiding bleeding complications at the puncture site with the Femo-Stop-SystemR during thrombolysis for pulmonary embolism after coronary angiography 1998
 12 S2 p. 98-
1 p.
 artikel
12 P22 Bolus administration of Streptokinase (750 000 i.u. over 10 minutes) a safe and efficient thrombolytic regimen in acute myocardial infarction 1998
 12 S2 p. 97-
1 p.
 artikel
13 P11 Clinical effect of Ancrod is primarily caused by the fibrinolytic response induced by desAA-fibrin formation 1998
 12 S2 p. 93-
1 p.
 artikel
14 P37 Comparison of a new rapid bedside assay for t-PA with a commercially available ELISA: Possible importance of t-PA antigen determination during thrombolytic therapy for prediction of outcome 1998
 12 S2 p. 102-
1 p.
 artikel
15 P01 Comparison of early patency and early ST resolution as predictors of cardiac mortality after thrombolysis for acute myocardial infarction 1998
 12 S2 p. 91-
1 p.
 artikel
16 P61 Correlation between impaired glucose tolerance, hyper-lipoproteinemia and fibrinogen toward coronary artery disease in sample of the midle aged-population of the district of western backa 1998
 12 S2 p. 111-
1 p.
 artikel
17 P36 Correlations between morphology and disturbed fibrinolysis in unstable angina pectoris 1998
 12 S2 p. 102-
1 p.
 artikel
18 P15 Differences in Leukocyte Adhesion of Macro- and Microvascular Endothelial Cells from Human Hearts 1998
 12 S2 p. 95-
1 p.
 artikel
19 P41 Dynamics of fibrinolytic blood activity in mild hypertension caused by exercise test 1998
 12 S2 p. 104-
1 p.
 artikel
20 P17 Endothelial and platelet NO release as well as [Ca2+]i are increased by the calciumantagonist nifedipine 1998
 12 S2 p. 95-
1 p.
 artikel
21 P18 Enoxaparin and accelerated streptokinase in acute myocardial infarction (CLEXAS study) 1998
 12 S2 p. 96-
1 p.
 artikel
22 P14 Expression of tissue factor and tissue factor pathway inhibitor during inflammation in vivo 1998
 12 S2 p. 95-
1 p.
 artikel
23 P45 Feasibility and cost-effectiveness of primary stenting in unstable angina pectoris — StiAP study 1998
 12 S2 p. 105-
1 p.
 artikel
24 P31 Flow cytometry and electropermeabilization: New approaches for analysis of intracellular signaling cascades in human platelets 1998
 12 S2 p. 100-
1 p.
 artikel
25 P53 Gemfibrozil inhibits specifically the expression of plasminogen activator inhibitor type 1 in adult arterial smooth muscle cells 1998
 12 S2 p. 108-
1 p.
 artikel
26 P10 Generation and disappearance of antihirudin antibodies during treatment with r-hirudin 1998
 12 S2 p. 93-
1 p.
 artikel
27 P42 Homocyst(e)ine and fibrinolytic response to standardized venous occlusion in patients with premature coronary heart disease 1998
 12 S2 p. 104-
1 p.
 artikel
28 P58 Impact of gender on outcome in the setting of unstable angina pectoris Braunwald classes I/II treated with coronary angioplasty 1998
 12 S2 p. 110-
1 p.
 artikel
29 P35 Increase of thrombomodulin after coronary angiography in patients with coronary heart disease 1998
 12 S2 p. 102-
1 p.
 artikel
30 P65 Influence of heparin, low molecular weight heparin and hirudin on the fibrinolytic potential of vascular smooth muscle cells. A passage dependent regulatory mechanism 1998
 12 S2 p. 112-
1 p.
 artikel
31 P62 Intercellular adhesion molecule-1 alterations precede the changes in plasminogen activator inhibitor in the early stages of atherosclerosis 1998
 12 S2 p. 111-
1 p.
 artikel
32 P08 Intraoperative emergency thrombolysis with rt-PA after early postoperative coronary artery bypass thrombosis 1998
 12 S2 p. 92-
1 p.
 artikel
33 P60 Ischemic myocardial dysfunction in patients with refractory angina pectoris and end-stage coronary artery disease — Hemodynamic relevance of long-term intermittent urokinase therapy 1998
 12 S2 p. 110-
1 p.
 artikel
34 P29 Is T-cadherin a signal-transducting receptor for lipoproteins? 1998
 12 S2 p. 100-
1 p.
 artikel
35 P06 Is there an influence of the time of admission to a hospital on the rate of thrombolysis in patients with acute myocardial infarction? 1998
 12 S2 p. 92-
1 p.
 artikel
36 P57 Laboratory-based diagnosis of acute coronary syndromes: Results of the NOWIS pilot study 1998
 12 S2 p. 109-
1 p.
 artikel
37 Platelet inhibition: new agents, new strategies, new trials Gulba, D.C.
 1998
 12 S2 p. 13-23
11 p.
 artikel
38 P55 Lesion morphology and plasma levels of C-reactive protein after coronary stent implantation 1998
 12 S2 p. 109-
1 p.
 artikel
39 P27 Long term follow-up after thrombolytic therapy in acute massive pulmonary embolism: Results from the step 2 trial 1998
 12 S2 p. 99-
1 p.
 artikel
40 P24 Long — term results — Multicenter lyse study 1998
 12 S2 p. 98-
1 p.
 artikel
41 P47 Neutrophil integrin expression in acute myocardial infarction: Influence of coronary angioplasty 1998
 12 S2 p. 106-
1 p.
 artikel
42 P67 Optimized preclinical management of acute stroke 1998
 12 S2 p. 113-
1 p.
 artikel
43 P34 Overexpression of the cytoskeletal protein VASP in CHO cells: Regulatory effects on expression of other cytoskeletal signaling proteins and on cell motility 1998
 12 S2 p. 101-
1 p.
 artikel
44 P56 PAI I gene polymorphism in patients with coronary heart disease and malignant ventricular arrhythmias 1998
 12 S2 p. 109-
1 p.
 artikel
45 P68 Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance 1998
 12 S2 p. 113-
1 p.
 artikel
46 P38 Platelet Membrane P-selectin and levels of soluble P-selectin following streptokinase therapy of myocardial infarction 1998
 12 S2 p. 103-
1 p.
 artikel
47 P03 Procoagulant effects of thrombolytic regimen in acute myocardial infarction 1998
 12 S2 p. 91-
1 p.
 artikel
48 P50 Proteinase-activated receptor-2 (PAR-2) mediates mitogenic responses in coronary artery smooth muscle cells. E. Bretschneider, *M. Braun 1998
 12 S2 p. 107-
1 p.
 artikel
49 P66 Quantification of neuronal and microvascular damage after focal cerebral ischemia and reperfusion 1998
 12 S2 p. 113-
1 p.
 artikel
50 P46 Restenosis after elective percutaneous transluminal coronary angioplasty Evidence for the relevance of a hypercoagulable disease state in clinically stable patients 1998
 12 S2 p. 106-
1 p.
 artikel
51 P20 Safety and efficiency of accelerated Streptokinase in the prehospital phase of acute myocardial infarction 1998
 12 S2 p. 96-
1 p.
 artikel
52 P39 Soluble fibrin and X-oligomer levels following streptokinase therapy of acute myocardial infarction: Dominance of coagulation over fibrinolysis beyond twelve hours 1998
 12 S2 p. 103-
1 p.
 artikel
53 P43 Spectrum of reperfusion strategies in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty 1998
 12 S2 p. 105-
1 p.
 artikel
54 P12 Sustained Anti-thrombotic Activity of a Sulphated Pentasaccharide, a pure Anti-Factor-Xa Inhibitor Administered as Unique Anticoagulant in Coronary Angioplasty 1998
 12 S2 p. 94-
1 p.
 artikel
55 P52 TGF-β1 and PDGFAB mediate the stimulatory effect of aggregating human platelets on the expression of VEGF in cultured vascular smooth muscle cells 1998
 12 S2 p. 108-
1 p.
 artikel
56 P16 The adhesion of polymorphonuclear leukocytes to human vascular endothelial cells is differentially regulated by prostacyclin and NO 1998
 12 S2 p. 95-
1 p.
 artikel
57 P54 The cell injury and death caused by hydrogen peroxide in human cardiomyoblasts is reduced by the EP3-receptor agonist ONO-AE-248 1998
 12 S2 p. 108-
1 p.
 artikel
58 P49 The cytoplasmic domain of tissue factor is sufficient to support cell adhesion and migration 1998
 12 S2 p. 107-
1 p.
 artikel
59 P25 The ECASS 3-h cohort: Secondary analysis of ECASS data by time stratification 1998
 12 S2 p. 98-
1 p.
 artikel
60 P32 The histone acetylase TIP60 forms higher ordered complexes with NF-κB p50/Bcl3 and activates P-Selectin gene expression 1998
 12 S2 p. 100-
1 p.
 artikel
61 P04 The more frequent use of rapid reperfusion therapy in patients with AMI between 1992 and 1996 may reduce intrahospital mortality 1998
 12 S2 p. 91-
1 p.
 artikel
62 P23 Therapeutic defibrinogenation using recombinant tissue plasminogen activator (rtpa) 1998
 12 S2 p. 98-
1 p.
 artikel
63 P19 The romanian multicentric study for accelerated streptokinase in acute myocardial infarction (ROMAS 1 study) 1998
 12 S2 p. 96-
1 p.
 artikel
64 P40 Thrombin-activatable fibrinolysis inhibitor (TAFI) activity following thrombolysis with streptokinase 1998
 12 S2 p. 103-
1 p.
 artikel
65 P07 Thrombolysis on patients over 65 years 1998
 12 S2 p. 92-
1 p.
 artikel
66 P02 Thrombolytic therapy with streptokinase and prolonged resuscitation in patients with acute myocardial infarction 1998
 12 S2 p. 91-
1 p.
 artikel
67 P63 Ticlopidin acts via inhibition of ADP stimulated VASP dephosphorylation 1998
 12 S2 p. 112-
1 p.
 artikel
68 P21 Treatment of acute myocardial infarction with rapid infussion of rt-pa over one hour period 1998
 12 S2 p. 97-
1 p.
 artikel
69 P51 Upregulation of integrin avβ3 during neointima formation in the rat aorta after balloon injury and expression in human atherosclerosis 1998
 12 S2 p. 107-
1 p.
 artikel
70 P33 Urokinase activates calcium-dependent potassium channels in U937 cells via a release of calcium from internal stores 1998
 12 S2 p. 101-
1 p.
 artikel
71 P30 Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells 1998
 12 S2 p. 100-
1 p.
 artikel
72 P13 Various GP IIb/IIIa (αIIb β3) Blockers Can Induce Fibrinogen Binding to GP IIb/IIIa and Platelet Aggregation 1998
 12 S2 p. 94-
1 p.
 artikel
73 Reperfusion therapy for myocardial infarction: principles established, application still evolving Ross, A.M.
 1998
 12 S2 p. 1-3
3 p.
 artikel
74 Revascularization for acute myocardial infarction: thrombolytic therapy or angioplasty — still a burning question Swan, H.J.C.
 1998
 12 S2 p. 5-11
7 p.
 artikel
75 Subject index 1998
 12 S2 p. 115-119
5 p.
 artikel
76 Thrombolysis in stroke: which agent, when and how Steiner, T.
 1998
 12 S2 p. 25-30
6 p.
 artikel
77 Thrombolytic agents — an updated overview Gulba, D.C.
 1998
 12 S2 p. 39-58
20 p.
 artikel
78 Thrombolytic therapy: can it prevent the development of post-thrombotic syndrome? Bounameaux, H.
 1998
 12 S2 p. 31-37
7 p.
 artikel
                             78 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland